Stay updated on Fisogatinib in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page
- Check2 days agoChange DetectedThe page now displays Revision: v3.6.5 instead of v3.6.4, indicating a small site update reflected in the page footer/metadata.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page footer now shows Revision: v3.6.4, replacing the previous v3.6.3. This indicates a software/template version update for the page without altering the study content.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3 on the page. This reflects a minor platform build update and does not modify study information or patient-facing content.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision label on the page updated from v3.6.0 to v3.6.2, indicating a minor platform update. The page's study details and listed locations remain unchanged.SummaryDifference0.0%

- Check60 days agoChange DetectedRecruitment status now indicates recruitment is closed. The page adds help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header formatting, along with a revision footer change from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check67 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a new version of the page. This appears to be a small maintenance update rather than changes to the study content.SummaryDifference0.0%

Stay in the know with updates to Fisogatinib in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.